MedPath

Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial

Not Applicable
Completed
Conditions
Critically Ill Adult Patients With Difficult Weaning
Interventions
Procedure: Non assisted strategy
Procedure: Assisted strategy
Registration Number
NCT03861117
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

The aim of this study is to assess if a bundle associating pressure support and positive end-expiratory pressure during spontaneous breathing trial and detection by T-piece of patients with high-risk of extubation failure can reduce the time to successful extubation in critically ill patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • Patient 18 years old or more
  • Intubated and ventilated in intensive care unit for more than 24 hours
  • Patient ready for weaning evaluation
  • Failure of a first T-piece SBT
Read More
Exclusion Criteria
  • Chronic neuromuscular disease
  • Guillain-Barré Syndrome
  • Central nervous system disease with consciousness disorder
  • Tracheostomy
  • Chronic disease with life expectancy less than 1 year
  • Pregnancy, breast feeding
  • Withholding life support regarding a reintubation
  • Prisoner or patient interned in psychiatric hospital
  • Guardianship
  • Language barrier
  • Lack of medical insurance
  • Lack of the patient's consent (or of the next of kin where appropriate)
  • Patient under an exclusion period after enrollment in another research study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non assisted strategyNon assisted strategyAbility to be weaned is determined with T-piece.
Assisted strategyAssisted strategyAbility to be weaned is determined with pressure support and positive end-expiratory pressure.
Primary Outcome Measures
NameTimeMethod
Time (hours) to successful extubation90 days

Successful extubation is defined as extubation without retintubation within the 7 following days.

Secondary Outcome Measures
NameTimeMethod
reintubation rate90 days

percentage (%) of the number of patients with any reintubation divided by the number of patients per group

ventilator-free days at Day 9090 days

90 minus the number of days spent on invasive mechanical ventilation (days) since inclusion. Zero day is allocated to dead patients.

Rate of first extubation90 days

percentage (%) of patients with a first successful extubation divided by the total number of patients per group

duration of non-invasive and invasive mechanical ventilation90 days

time (hours) spent on invasive or non mechanical ventilation since inclusion

Day 90 mortality90 days

percentage (%) of patients dead at Day 90

Intensive care unit length of stay90 days

time (days) spent in intensive care unit from inclusion until discharge or death

Invasive mechanical ventilation duration90 days

time (hours) spent on invasive mechanical ventilation since inclusion

hospital length of stay90 days

time (days) spent in the hospital from inclusion until discharge or death

Trial Locations

Locations (1)

Hôpital de la Croix-Rousse

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath